Exploring the Possibilities of Clinical Trials in the CEE
About The Webinar
With clinical trials becoming increasingly global and significantly higher in the developed biotech and pharma markets, clinical decision-makers must look closely at all possible options laid on the table. One such option, which has proven to provide abundant opportunities is the Central and Eastern European region. While this region holds many possibilities, each country also varies in its benefits, regulatory processes and submission guidelines.
In this webinar Dr. Natalia Fetkovska (SanaClis) shares the many characteristics of clinical trial conduct in Central and Eastern Europe and the differences by countries.
Her insightful presentation will be followed by a unique case study from the renowned Dr. Elke Bestel (PregLem). She reveals her experience in conducting clinical trials in this dynamic and fast-growing zone.
This 60 minute complimentary webinar covers strategies and best practices to :
Dr.Elke Bestel is Chief Medical Officer at PregLem. She joined PregLem in 2008 and acted as Global Project Director for ESMYA (Ulipristal Acetate 5mg) and was responsible for the set-up and conduct of the two pivotal Phase III trials leading to the registration of ESMYA 5mg tablets in 2012. Before joining PregLem Elke worked at Galderma (Sophia Antipolis, France) where she was responsible for various clinical development projects in dermatological indications such as acne, rosacea and psoriasis, and was involved in the clinical studies and submission of EPIDUO®. Prior to this, she gained experience in clinical trial management working as a Project Manager for MDS Pharma Services, nowadays INC Research (Sèvres, France). Elke holds a medical degree from the Georg-August-University of Göttingen. She received gynaecologic training in two hospitals in Switzerland and started in 1996 her career in the pharmaceutical industry.
Natalia Fetkovska, MD, PhD has more than 20 years experience in managing clinical trials in Central & Eastern Europe including management of supplies. She played a key role in establishing and expanding Quintiles operations in C&EE especially in Russia and Ukraine (1996-2005). Since 2006 Natalia purchased majority ownership rights in SanaClis and acts as Senior Partner. She is actively involved in strategic business planning, key customer contacts and successful company growth.
Chief Medical Officer
Natalia Fetkovska, MD, PhD
About Our Speakers
In partnership with
Evaluate the benefits of a rapid recruitment in a widely available patient population
Reduce clinical study timelines and overall development costs, through more effective enrolment
Differentiate between the benefits, risks and regulatory processes of each country